These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics. Rowinsky EK; Donehower RC Pharmacol Ther; 1991 Oct; 52(1):35-84. PubMed ID: 1687171 [TBL] [Abstract][Full Text] [Related]
3. [Antimicrotubule agents]. Niitani H; Hisakatsu S Gan To Kagaku Ryoho; 1993 Jan; 20(1):34-41. PubMed ID: 8093658 [TBL] [Abstract][Full Text] [Related]
4. Phase I and pharmacodynamic study of taxol in refractory acute leukemias. Rowinsky EK; Burke PJ; Karp JE; Tucker RW; Ettinger DS; Donehower RC Cancer Res; 1989 Aug; 49(16):4640-7. PubMed ID: 2568175 [TBL] [Abstract][Full Text] [Related]
5. Taxol: a new and effective anti-cancer drug. Slichenmyer WJ; Von Hoff DD Anticancer Drugs; 1991 Dec; 2(6):519-30. PubMed ID: 1687206 [TBL] [Abstract][Full Text] [Related]
6. Taxol: a new agent active in melanoma and ovarian cancer. Einzig AI; Wiernik PH; Schwartz EL Cancer Treat Res; 1991; 58():89-100. PubMed ID: 1683787 [No Abstract] [Full Text] [Related]
7. Structure-activity study on the actions of taxol and related taxanes on primary cultures of adrenal medullary cells. McKay DB J Pharmacol Exp Ther; 1989 Mar; 248(3):1302-7. PubMed ID: 2564892 [TBL] [Abstract][Full Text] [Related]
8. Laboratory scientists mount intensive probe of taxol's mechanism of action. Reynolds T J Natl Cancer Inst; 1991 Jul; 83(13):904-6. PubMed ID: 1676760 [No Abstract] [Full Text] [Related]
9. Taxol: the first of the taxanes, an important new class of antitumor agents. Rowinsky EK; Onetto N; Canetta RM; Arbuck SG Semin Oncol; 1992 Dec; 19(6):646-62. PubMed ID: 1361079 [TBL] [Abstract][Full Text] [Related]
10. Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines. Speicher LA; Barone L; Tew KD Cancer Res; 1992 Aug; 52(16):4433-40. PubMed ID: 1353706 [TBL] [Abstract][Full Text] [Related]
11. Microtubules, organelle transport, and steroidogenesis in cultured adrenocortical tumor cells. 2. Reversibility of taxol's inhibition of basal and ACTH-induced steroidogenesis is unaccompanied by reversibility of taxol-induced changes in cell ultrastructure. Benis R; Mattson P Tissue Cell; 1989; 21(5):687-98. PubMed ID: 2575805 [TBL] [Abstract][Full Text] [Related]
12. Cardiac disturbances during the administration of taxol. Rowinsky EK; McGuire WP; Guarnieri T; Fisherman JS; Christian MC; Donehower RC J Clin Oncol; 1991 Sep; 9(9):1704-12. PubMed ID: 1678781 [TBL] [Abstract][Full Text] [Related]
14. [Antimitotic agents]. Fukuoka K; Saijo N Gan To Kagaku Ryoho; 1997 Sep; 24(11):1519-25. PubMed ID: 9309150 [TBL] [Abstract][Full Text] [Related]
15. Taxol: an important new drug in the management of epithelial ovarian cancer. Markman M Yale J Biol Med; 1991; 64(6):583-90. PubMed ID: 1687343 [TBL] [Abstract][Full Text] [Related]
16. [Microtubules and antineoplastic drugs]. Arioka H; Saijo N Gan To Kagaku Ryoho; 1994 Apr; 21(5):583-90. PubMed ID: 7908790 [TBL] [Abstract][Full Text] [Related]
17. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism. Derry WB; Wilson L; Jordan MA Cancer Res; 1998 Mar; 58(6):1177-84. PubMed ID: 9515803 [TBL] [Abstract][Full Text] [Related]
18. Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages. Bogdan C; Ding A J Leukoc Biol; 1992 Jul; 52(1):119-21. PubMed ID: 1353517 [TBL] [Abstract][Full Text] [Related]